405 related articles for article (PubMed ID: 18627350)
1. Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1.
Luo M; Delaplane S; Jiang A; Reed A; He Y; Fishel M; Nyland RL; Borch RF; Qiao X; Georgiadis MM; Kelley MR
Antioxid Redox Signal; 2008 Nov; 10(11):1853-67. PubMed ID: 18627350
[TBL] [Abstract][Full Text] [Related]
2. Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth.
Fishel ML; Jiang Y; Rajeshkumar NV; Scandura G; Sinn AL; He Y; Shen C; Jones DR; Pollok KE; Ivan M; Maitra A; Kelley MR
Mol Cancer Ther; 2011 Sep; 10(9):1698-708. PubMed ID: 21700832
[TBL] [Abstract][Full Text] [Related]
3. Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer.
Singh-Gupta V; Joiner MC; Runyan L; Yunker CK; Sarkar FH; Miller S; Gadgeel SM; Konski AA; Hillman GG
J Thorac Oncol; 2011 Apr; 6(4):688-98. PubMed ID: 21325978
[TBL] [Abstract][Full Text] [Related]
4. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML; Kelley MR
Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of novel analogues of E3330 that block the redox signaling activity of the multifunctional AP endonuclease/redox signaling enzyme APE1/Ref-1.
Kelley MR; Luo M; Reed A; Su D; Delaplane S; Borch RF; Nyland RL; Gross ML; Georgiadis MM
Antioxid Redox Signal; 2011 Apr; 14(8):1387-401. PubMed ID: 20874257
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration.
Zou GM; Maitra A
Mol Cancer Ther; 2008 Jul; 7(7):2012-21. PubMed ID: 18645011
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
[TBL] [Abstract][Full Text] [Related]
8. A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity.
Ando K; Hirao S; Kabe Y; Ogura Y; Sato I; Yamaguchi Y; Wada T; Handa H
Nucleic Acids Res; 2008 Aug; 36(13):4327-36. PubMed ID: 18586825
[TBL] [Abstract][Full Text] [Related]
9. Suppression of choroidal neovascularization through inhibition of APE1/Ref-1 redox activity.
Li Y; Liu X; Zhou T; Kelley MR; Edwards PA; Gao H; Qiao X
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4461-9. PubMed ID: 24970265
[TBL] [Abstract][Full Text] [Related]
10. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
[TBL] [Abstract][Full Text] [Related]
11. APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.
Cardoso AA; Jiang Y; Luo M; Reed AM; Shahda S; He Y; Maitra A; Kelley MR; Fishel ML
PLoS One; 2012; 7(10):e47462. PubMed ID: 23094050
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of the redox activity of ape1/ref-1 by e3330 blocks tnf-α-induced activation of IL-8 production in liver cancer cell lines.
Cesaratto L; Codarin E; Vascotto C; Leonardi A; Kelley MR; Tiribelli C; Tell G
PLoS One; 2013; 8(8):e70909. PubMed ID: 23967134
[TBL] [Abstract][Full Text] [Related]
13. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.
Logsdon DP; Grimard M; Luo M; Shahda S; Jiang Y; Tong Y; Yu Z; Zyromski N; Schipani E; Carta F; Supuran CT; Korc M; Ivan M; Kelley MR; Fishel ML
Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970
[TBL] [Abstract][Full Text] [Related]
14. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
[TBL] [Abstract][Full Text] [Related]
15. NMR studies reveal an unexpected binding site for a redox inhibitor of AP endonuclease 1.
Manvilla BA; Wauchope O; Seley-Radtke KL; Drohat AC
Biochemistry; 2011 Dec; 50(48):10540-9. PubMed ID: 22032234
[TBL] [Abstract][Full Text] [Related]
16. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.
Zou GM; Karikari C; Kabe Y; Handa H; Anders RA; Maitra A
J Cell Physiol; 2009 Apr; 219(1):209-18. PubMed ID: 19097035
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization.
Li Y; Liu X; Zhou T; Kelley MR; Edwards P; Gao H; Qiao X
Redox Biol; 2014; 2():485-94. PubMed ID: 24624338
[TBL] [Abstract][Full Text] [Related]
18. Knock-in reconstitution studies reveal an unexpected role of Cys-65 in regulating APE1/Ref-1 subcellular trafficking and function.
Vascotto C; Bisetto E; Li M; Zeef LA; D'Ambrosio C; Domenis R; Comelli M; Delneri D; Scaloni A; Altieri F; Mavelli I; Quadrifoglio F; Kelley MR; Tell G
Mol Biol Cell; 2011 Oct; 22(20):3887-901. PubMed ID: 21865600
[TBL] [Abstract][Full Text] [Related]
19. Going APE over ref-1.
Evans AR; Limp-Foster M; Kelley MR
Mutat Res; 2000 Oct; 461(2):83-108. PubMed ID: 11018583
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel quinone inhibitors targeted to the redox function of apurinic/apyrimidinic endonuclease 1/redox enhancing factor-1 (Ape1/ref-1).
Nyland RL; Luo M; Kelley MR; Borch RF
J Med Chem; 2010 Feb; 53(3):1200-10. PubMed ID: 20067291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]